Mark Hartley breaks down why 3i Group's one of the most profitable companies on the FTSE 100, and the risks investors need to watch out for. The post 3i Group: unravelling the finances behind one of ...

The industry is delivering strong returns to investors and has more potential to extend its benefits to employees ...

The Safex Chemicals IPO will be a combination of fresh issuance of equity shares worth Rs 450 crore, and an offer-for-sale ...

Venture capitalists made more deals in the sector in 2024 than in the past decade, with good and bad outcomes for patients ...

OpenAI has openly criticized Robinhood for its new token giveaway under the name “OpenAI tokens,” cautioning that these ...

Singapore investment major Temasek and billionaire Dr Ranjan Pai-led Manipal Hospitals is poised to win the hotly contested ...

More than 700 ETFs launched last year, including ones that hold crypto or make leveraged bets on individual stocks like ...

Under the terms of the deal, GIC, one of the world’s biggest institutional investors, and healthcare-focused private equity group Linden Capital Partners will buy out a minority stake owned by rival ...

But markets, including those in Europe, have since bounced back. The VIX, Wall Street's "fear gauge", has fallen around 67% ...

Private equity may bring capital, scale and infrastructure to physician groups, but it can’t replace physician control. Without buy-in from physicians, even the most well-funded deal can unravel.